Literature DB >> 23695516

MR perfusion in and around the contrast-enhancement of primary CNS lymphomas.

Stella Blasel1, Alina Jurcoane, Oliver Bähr, Lutz Weise, Patrick N Harter, Elke Hattingen.   

Abstract

Diffuse cerebral infiltration of primary brain tumors may be missed on conventional MRI. In glioblastomas it may be visible on MR-perfusion images as an elevated rCBV adjacent to the contrast enhancing area (penumbra). We aimed to evaluate whether penumbral rCBV of primary central nervous system lymphomas (PCNSL) is also increased and if PCNSL perfusion has different features than that of glioblastomas. We measured dynamic susceptibility contrast MR-perfusion at 3 Tesla in 38 presurgical patients with histopathological diagnosis of PCNSL (n = 19) and glioblastoma (n = 19). We compared normalized rCBV within and adjacent to the enhancing area and evaluated time-signal intensity curves (TSIC) in all patients. Histopathological comparison of patients with different TSIC patterns (with or without shoulder-like increase) was performed. Relative to the normal tissue, rCBV within and adjacent to the enhancing area was increased (p < 0.05) in both glioblastomas and PCNSL. In the penumbra the increase was moderate in both groups, with 1.4 ± 0.46 in PCNSL and 1.82 ± 0.82 in glioblastomas (p = 0.07 between groups). In the enhancing tumor the increase was moderate in PCNSL (1.46 ± 0.62) and marked in glioblastomas (4.13 ± 2.44) (p < 0.001 between groups). A shoulder-like TSIC increase was exclusively found in PCNSL (11/19) and was significantly associated with a less prominent reticulin fibre network compared to the PCNSL without a shoulder-like TSIC increase. The moderately increased penumbral rCBV in PCNSL and glioblastomas reveals tumor-related changes beyond the tumor borders which are invisible with conventional MRI. PCNSL can be differentiated from glioblastomas through their significantly lower rCBV and shoulder-like signal intensity changes inside the enhancing area.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23695516     DOI: 10.1007/s11060-013-1161-z

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  48 in total

Review 1.  Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging.

Authors:  Soonmee Cha; Edmond A Knopp; Glyn Johnson; Stephan G Wetzel; Andrew W Litt; David Zagzag
Journal:  Radiology       Date:  2002-04       Impact factor: 11.105

2.  Endothelial hyperplasia and endothelial galectin-3 expression are prognostic factors in primary central nervous system lymphomas.

Authors:  Nicky D'Haene; Xavier Catteau; Calliope Maris; Benoit Martin; Isabelle Salmon; Christine Decaestecker
Journal:  Br J Haematol       Date:  2007-12-13       Impact factor: 6.998

3.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis.

Authors:  L Ostergaard; R M Weisskoff; D A Chesler; C Gyldensted; B R Rosen
Journal:  Magn Reson Med       Date:  1996-11       Impact factor: 4.668

4.  Vascular patterns in cerebral neoplasms and their differential diagnosis.

Authors:  J H Scatliff; F C Guinto; W B Radcliffe
Journal:  Semin Roentgenol       Date:  1971-01       Impact factor: 0.800

5.  Vascular structure of glioblastomas.

Authors:  J H Scatliff; W B Radcliffe; H H Pittman; C H Park
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1969-04

6.  Angiogenesis in primary central nervous system lymphoma (PCNSL).

Authors:  Hiroaki Takeuchi; Ken Matsuda; Ryuhei Kitai; Kazufumi Sato; Toshihiko Kubota
Journal:  J Neurooncol       Date:  2007-04-04       Impact factor: 4.130

7.  Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.

Authors:  Bahattin Hakyemez; Cuneyt Erdogan; Naile Bolca; Nalan Yildirim; Gokhan Gokalp; Mufit Parlak
Journal:  J Magn Reson Imaging       Date:  2006-10       Impact factor: 4.813

8.  Elevated peritumoural rCBV values as a mean to differentiate metastases from high-grade gliomas.

Authors:  Stella Blasel; Alina Jurcoane; Kea Franz; Gerald Morawe; Stefanie Pellikan; Elke Hattingen
Journal:  Acta Neurochir (Wien)       Date:  2010-08-27       Impact factor: 2.216

9.  Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood-brain-barrier.

Authors:  S Heiland; T Benner; J Debus; K Rempp; W Reith; K Sartor
Journal:  Magn Reson Imaging       Date:  1999-01       Impact factor: 2.546

Review 10.  FSL.

Authors:  Mark Jenkinson; Christian F Beckmann; Timothy E J Behrens; Mark W Woolrich; Stephen M Smith
Journal:  Neuroimage       Date:  2011-09-16       Impact factor: 6.556

View more
  8 in total

1.  Is deep brain involvement in intracranial primary central nervous system lymphoma of importance for penetration of chemotherapeutic agents?

Authors:  Torstein R Meling; Anna Latysheva; Michele Da Broi; Guro Jahr; Harald Holte; Klaus Beiske; Kyrre Eeg Emblem
Journal:  Neuroradiology       Date:  2018-05-27       Impact factor: 2.804

2.  [Interdisciplinary neuro-oncology: part 1: diagnostics and operative therapy of primary brain tumors].

Authors:  G Tabatabai; E Hattingen; J Schlegel; W Stummer; U Schlegel
Journal:  Nervenarzt       Date:  2014-08       Impact factor: 1.214

3.  Alterations of the Blood-Brain Barrier and Regional Perfusion in Tumor Development: MRI Insights from a Rat C6 Glioma Model.

Authors:  Monika Huhndorf; Amir Moussavi; Nadine Kramann; Olga Will; Kirsten Hattermann; Christine Stadelmann; Olav Jansen; Susann Boretius
Journal:  PLoS One       Date:  2016-12-22       Impact factor: 3.240

Review 4.  Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges.

Authors:  Junfeng Zhang; Heng Liu; Haipeng Tong; Sumei Wang; Yizeng Yang; Gang Liu; Weiguo Zhang
Journal:  Contrast Media Mol Imaging       Date:  2017-03-20       Impact factor: 3.161

5.  Differentiation of malignant brain tumor types using intratumoral and peritumoral radiomic features.

Authors:  Dongming Liu; Jiu Chen; Honglin Ge; Xinhua Hu; Kun Yang; Yong Liu; Guanjie Hu; Bei Luo; Zhen Yan; Kun Song; Chaoyong Xiao; Yuanjie Zou; Wenbin Zhang; Hongyi Liu
Journal:  Front Oncol       Date:  2022-07-28       Impact factor: 5.738

6.  Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced MR in Tumor Parenchyma and Peritumoral Area for Distinction of Brain Tumors.

Authors:  Jing Zhao; Zhi-yun Yang; Bo-ning Luo; Jian-yong Yang; Jian-ping Chu
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

Review 7.  Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring.

Authors:  C Chiavazza; A Pellerino; F Ferrio; A Cistaro; R Soffietti; R Rudà
Journal:  Biomed Res Int       Date:  2018-06-21       Impact factor: 3.411

8.  Delayed Contrast Enhancement in Magnetic Resonance Imaging and Vascular Morphology of Primary Diffuse Large B-Cell Lymphoma (DLBCL) of the Central Nervous System (CNS): A Retrospective Study.

Authors:  Dandan Liu; Xiaojun Liu; Zhaogui Ba; Limei Xie; Jiwu Han; Dexin Yu; Xiangxing Ma
Journal:  Med Sci Monit       Date:  2019-05-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.